Events
Event
ACI Summit on Biosimilars & Innovator Biologics Virtual Conference
On September 23, Axinn partner Aziz Burgy spoke at the ACI Summit on Biosimilars & Innovator Biologics Virtual Conference.
Aziz spoke on a panel entitled, "The Economics of Biosimilars: Considerations for Market Access, Sustainable Pricing and Reimbursement Policies." This panel analyzed the California legislation aimed at ending pay-for-delay in pharmaceutical patent infringement settlements. Speakers reviewed the implications of the House passed Lower Drug Costs Now Act.
Click here for more information.
To subscribe to our publications, click here.